Discover how therapeutic peptides act as biological messengers to treat disease, improve metabolism, and enhance immune ...

Recurrent severe diarrhea with acute kidney injury after drug reinitiation highlights a rare but serious enteropathy linked ...

SELECT was a large study focused on obesity and cardiovascular disease in people without type 2 diabetes, but it included kidney outcomes as a secondary end point. The data showed that semaglutide ...

The Phase III study FIND-CKD ( NCT05047263) — investigating the efficacy and safety of KERENDIA ® (finerenone) versus placebo when added to standard of care in adult patients with non-diabetic chronic ...

Bayer announces finerenone meets primary endpoint in pivotal phase III FIND-CKD study in patients with non-diabetic chronic kidney disease: Berlin Tuesday, March 17, 2026, 15:00 H ...

If Kerendia secures a label expansion, it would become available to more than half of the overall CKD patient population who ...

Chronic Kidney Disease (CKD) has become a growing challenge. A top doctor shared some of its main causes, ways to prevent it from becoming serious, and how to manage it through diet and early medical ...

Dimerix to conduct blinded review of ACTION3 data later this month to confirm statistical assumptions for primary endpoint ... Read More The post Dimerix to conduct blinded review of phase III kidney ...

Angiotensin-converting enzyme inhibitors (ACEi) are the leading cause of drug-induced angioedema in the USA, with an ...

BACKGROUND: Premature atrial contractions (PACs) are independently associated with atrial fibrillation, stroke, and heart failure, yet no pharmacological therapy is approved for PAC suppression.

High blood pressure, also called hypertension, is a very common health problem around the world. Many people may not feel any ...

Camber is expanding its launching four new generics. The company is releasing plerixafor injection, which is a generic for Mozobil. It is available in 24 mg/1.2 ml (20 mg/ml). Ple ...